Opioid Induced Constipation Treatment Market

Q: What will be the CAGR of the global opioid induced constipation treatment industry during the forecast period?

The CAGR is anticipated to be 5.3% from 2026 to 2036 Read More

Opioid Induced Constipation Treatment Market (Therapy Type: Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs), Chloride Channel Activators, Traditional Laxatives and Others; Drug Type: Branded Drugs and Generic Drugs; and Prescription Type: Over-The-Counter and Prescription) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Opioid Induced Constipation Treatment Market Outlook 2036

The global opioid induced constipation treatment market was valued at US$ 2.9 Bn in 2025 and is projected to reach US$ 5.2 Bn by 2036, expanding at a CAGR of 5.3% from 2026 to 2036. The market growth is driven by increased opioid use for chronic pain and post-surgical care, a growing elderly population, and a rise in awareness of OIC.

Market Size & Highlights

The opioid induced constipation treatment industry reached US$ 2.9 Billion in 2025.
The opioid induced constipation treatment market is expected to climb to US$ 5.2 Billion by 2036.
The opioid induced constipation treatment industry is anticipated to expand at a CAGR of 5.3% from 2026 to 2036.
Top companies in the market include AstraZeneca, DAIICHI SANKYO COMPANY, LIMITED and Takeda Pharmaceutical Company Limited.
North America dominated the market in 2025, holding the largest revenue share of 43.7%.
By Therapy Type, the Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) segment held the major market share of 65.4% in 2025.

Opioid Induced Constipation Treatment Market By Revenue

Analysts’ Viewpoint regarding Opioid Induced Constipation Treatment Market

Several factors are driving the growth of the opioid-induced constipation treatment market for both - clinical and outpatient settings. Some of these factors are growing interest in gastrointestinal health, increased healthcare expenditure on supportive care, rising awareness among prescribers regarding the side-effects of opioids and enhanced diagnostics for opioid-induced disorders.

Some of the ongoing trends include the usage of real-world evidence, patient-reported outcome measures, rise of digital therapeutics for symptom monitoring, increased generic competition leading to cost optimization, more focus on biomarker-driven therapy selection, and the use of value-based contracting to show benefits.

The competitive landscape is focused on the increased R&D expenditure, use of strategic partnerships for pipeline acceleration, lifecycle management of current agents, enhancement of patient support programs, manufacturing scale-up to increase access, differentiated pricing strategies, regulatory submissions, and use of digital adherence and monitoring tools.

Opioid Induced Constipation Treatment Market Introduction

OIC treatment refers to therapeutic measures that provide relief from constipation caused by opioid medications. On the other hand, opioids that are very effective in pain management, affect the receptors within the gastro-intestinal system, thereby reducing bowel motility and fluid secretion.

OIC treatments essentially break the target intervention by counteracting the effect of the opioids on the gut or by promoting bowel movement through either the pharmacological or non-pharmacological means. The traditional treatment methods entail the use of laxatives, stool softeners, and diet adjustment, which at best provide temporary relief as they cannot target opioid receptor activity.

The use of peripherally mu-opioid receptor antagonists (PAMORAs) is a major change to the treatment of OIC. There are also some other potential therapies such as prokinetic agents and chloride channel activators that can improve intestinal motility besides these drugs.

Opioid induced constipation treatment is essential for patient comfort, medication adherence, and overall well-being of patients on long-term opioid therapy. The rising emphasis on supportive care strategies has been instrumental in further research and development in this therapeutic area.

Attribute	Detail
Opioid Induced Constipation Treatment Market Drivers	Higher Prevalence of Chronic Pain Increasing Use of Opioids for Pain Management

Higher Prevalence of Chronic Pain is Fostering Opioid Induced Constipation Treatment Market Share

The rising incidence of chronic pain conditions like arthritis, neuropathic disorders, and cancer are the major driving forces for the opioid-induced constipation treatment market. Opioids are used as principal drugs for the treatment of moderate to severe pain conditions.

Chronic pain patients frequently need long-term opioid therapy and are thus prone to its gastrointestinal side effects. This lingering problem has created a need for an OIC solution that would alleviate patients not only from constipation but also not diminish the analgesic effect of opioids, thus enabling uninterrupted and effective pain management.

Health professionals these days are focusing more on the goal of complete pain management, including management of analgesia and its side-effects. This, in turn, has resulted in the use of highly targeted treatments for OIC, such as PAMORAs, and newer oral Drug Types that help alleviate symptoms without changing pain control.

Besides, the initiation of awareness programs and provision of patient education about the side-effects of opioids have been the major contributors to early diagnosis and intervention of OIC. Therefore, the increase in chronic pain volume continues to be the key market driver that supports investment in research, product innovations, and extended reach for the targeted treatment of opioid-induced constipation.

Increasing Use of Opioids for Pain Management is Propelling Opioid Induced Constipation Treatment Market Share

Increase in the consumption of opioids for the management of pain is the driving force behind the growth of the opioid-induced constipation medication market. Opioids provide relief from moderate to severe pain experienced as a result of cancer, recovery after surgery, chronic illness, and disorders associated with the skeletal system.

Opioids stimulate gastrointestinal receptors, which can cause constipation, one of the many negative side effects of these medications although they are highly effective. The prevalence of OIC continues to rise with global use, thus increasing demand for safe and effective therapeutic interventions to manage the condition.

One of the major goals of healthcare professionals is the implementation of extensive strategies for pain management that aim at reducing pain and side-effects simultaneously. The same shift has led to the use of specific OIC therapies like peripherally acting mu-opioid receptor antagonists (PAMORAs) and new oral Drug Types, which alleviate symptoms without interfering with pain control.

Furthermore, the wider availability of opioid drugs in has driven the demand for palliative care solutions. This has resulted in an increase in the number of patients on opioids as one of the major impellers that pushes the pharmaceutical industry to innovate, raise awareness clinically, and integrate treatments in the management of opioid-induced constipation.

Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) Leading Global Opioid Induced Constipation Treatment Market

Opioid Induced Constipation Treatment Market By Type

PAMORAs or Peripherally Acting µ-Opioid Receptor Antagonists are the leading agents in the opioid induced constipation treatment industry as they are the only drugs that specifically localize the root cause of constipation without marring the other beneficial effects of opioids, namely analgesia. Their mode of operation makes it possible to achieve effective gastrointestinal relief, thus maintaining central analgesia.

Regional Outlook of Opioid Induced Constipation Treatment Market

Opioid Induced Constipation Treatment Market By Region

Attribute	Detail
Leading Region	North America

North America represented a significant marketing opportunity in the opioid-induced constipation therapeutics space with an estimated market share of 43.7% during 2025. This is primarily attributed to the high use of opioids to manage chronic and post-surgical pain within North America. The well-developed healthcare system of the area not only facilitates the identification and treatment of OIC but also supports it with sophisticated diagnostics and a high degree of clinical awareness.

Besides, the growth of the market is backed by favorable reimbursement policies, robust pharmaceutical research, and continuous product innovation. Also, the introduction of highly targeted therapies like peripherally acting µ-opioid receptor antagonists (PAMORAs) and presence of large industry players are helping to increase the share of North America in the worldwide opioid induced constipation treatment market.

Analysis of Key Players in Opioid Induced Constipation Treatment Market

Organizations that operate in the opioid-induced constipation treatment market are progressively putting more emphasis on strategic partnerships, research and development, and the expansion of product portfolios.

Salix Pharmaceuticals, AstraZeneca, DAIICHI SANKYO COMPANY, LIMITED, Takeda Pharmaceutical Company Limited, Mallinckrodt, Shionogi & Co., Ltd., Ironwood, Nektar Therapeutics and Cigna Healthcare are some of the leading players operating in the global opioid induced constipation treatment market.

Each of these players has been profiled in the opioid induced constipation treatment market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Opioid Induced Constipation Treatment Market

In May 2025, Shionogi & Co., Ltd. declared that its New Drug Application for naldemedine tosilfate (naldemedine) was approved in China for the treatment of opioid-induced constipation. Naldemedine is a drug made by Shionogi that works peripherally on µ-opioid receptors.

Opioid Induced Constipation Treatment Market Snapshot

Attribute	Detail
Size in 2025	US$ 2.9 Bn
Forecast Value in 2036	US$ 5.2 Bn
CAGR	5.3%
Forecast Period	2026-2036
Historical Data Available for	2021-2024
Quantitative Units	US$ Bn
Opioid Induced Constipation Treatment Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Therapy Type Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) Chloride Channel Activators Traditional Laxatives Others (Prokinetics, etc.) Drug Type Branded Drugs Generic Drugs Prescription Type Over-The-Counter Prescription Route of Administration Oral Subcutaneous Others (Rectal, etc.) Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China Australia India Japan South Korea ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	Salix Pharmaceuticals AstraZeneca DAIICHI SANKYO COMPANY, LIMITED Takeda Pharmaceutical Company Limited Mallinckrodt Shionogi & Co., Ltd. Ironwood Nektar Therapeutics Cigna Healthcare
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global opioid induced constipation treatment market in 2025?

The global opioid induced constipation treatment market was valued at US$ 2.9 Bn in 2025

How big will the global opioid induced constipation treatment industry be in 2036?

The global opioid induced constipation treatment industry is projected to reach more than US$ 5.2 Bn by the end of 2036

What are the factors driving the opioid induced constipation treatment market?

The increasing use of opioid for chronic pain and post-surgical care, a growing elderly population, a rise in awareness of OIC, government approvals for new OIC treatments and advancements in healthcare infrastructure, are some of the factors driving the expansion of opioid induced constipation treatment market.

What will be the CAGR of the global opioid induced constipation treatment industry during the forecast period?

The CAGR is anticipated to be 5.3% from 2026 to 2036

Who are the prominent players in the global opioid induced constipation treatment market?

Salix Pharmaceuticals, AstraZeneca, DAIICHI SANKYO COMPANY, LIMITED, Takeda Pharmaceutical Company Limited, Mallinckrodt, Shionogi & Co., Ltd., Ironwood, Nektar Therapeutics and Cigna Healthcare

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Opioid Induced Constipation Treatment Market
Market Overview
- Introduction
  - Segment Definition
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Opioid Induced Constipation Treatment Market Analysis and Forecast, 2021-2036
  - Market Revenue Projections (US$ Bn)
Key Insights
- Healthcare Expenditure across Key Countries / Regions
- Recent Advancements in Opioid Induced Constipation Treatment
- Pricing Trends for Opioid Induced Constipation Treatment
- Regulatory Scenario across Key Regions / Countries
- PORTER’s Five Forces Analysis
- PESTLE Analysis
- Go-to-Market Strategy for New Market Entrants
- Key Purchase Metrics for End-users
- Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
- Benchmarking of the Products Offered by the Leading Competitors
Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Therapy Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Attractiveness Analysis, by Therapy Type
Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Drug Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Attractiveness Analysis, by Drug Type
Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Prescription Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Attractiveness Analysis, by Prescription Type
Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Route of Administration
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Attractiveness Analysis, by Route of Administration
Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Distribution Channel
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis, by Distribution Channel
Global Opioid Induced Constipation Treatment Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2021-2036
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country, 2021-2036
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
  - By Country
U.S. Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Canada Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Europe Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
Germany Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
UK Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
France Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Italy Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Spain Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
The Netherlands Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Rest of Europe Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Asia Pacific Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - China
  - India
  - Japan
  - South Korea
  - Australia & New Zealand
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
China Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
India Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Japan Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
South Korea Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Australia & New Zealand Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
ASEAN Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Rest of Asia Pacific Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Latin America Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
Brazil Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Argentina Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Mexico Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Rest of Latin America Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Middle East & Africa Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
  - By Country/Sub-region
GCC Countries Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
South Africa Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Therapy Type, 2021-2036
  - Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs)
  - Chloride Channel Activators
  - Traditional Laxatives
  - Others
- Market Value Forecast, by Drug Type, 2021-2036
  - Branded Drugs
  - Generic Drugs
- Market Value Forecast, by Prescription Type, 2021-2036
  - Over-The-Counter
  - Prescription
- Market Value Forecast, by Route of Administration, 2021-2036
  - Oral
  - Subcutaneous
  - Others
- Market Value Forecast, by Distribution Channel, 2021-2036
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis
  - By Therapy Type
  - By Drug Type
  - By Prescription Type
  - By Route of Administration
  - By Distribution Channel
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2025)
- Company Profiles
  - Salix Pharmaceuticals
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - AstraZeneca
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - DAIICHI SANKYO COMPANY, LIMITED
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Takeda Pharmaceutical Company Limited
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Mallinckrodt
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Shionogi & Co., Ltd.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Ironwood
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Nektar Therapeutics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Cigna Healthcare
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Other Prominent Players

List of Tables

Table 01: Global Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 02: Global Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 03: Global Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 04: Global Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 05: Global Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 06: Global Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Region, 2021 to 2036
Table 07: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, by Country, 2021-2036
Table 08: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 09: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 10: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 11: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 12: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 13: U.S. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 14: U.S. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 15: U.S. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 16: U.S. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 17: U.S. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 18: Canada Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 19: Canada Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 20: Canada Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 21: Canada Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 22: Canada Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 23: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 24: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 25: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 26: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 27: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 28: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 29: Germany Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 30: Germany Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 31: Germany Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 32: Germany Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 33: Germany Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 34: U.K. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 35: U.K. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 36: U.K. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 37: U.K. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 38: U.K. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 39: France Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 40: France Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 41: France Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 42: France Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 43: France Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 44: Italy Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 45: Italy Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 46: Italy Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 47: Italy Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 48: Italy Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 49: Spain Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 50: Spain Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 51: Spain Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 52: Spain Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 53: Spain Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 54: The Netherlands Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 55: The Netherlands Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 56: The Netherlands Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 57: The Netherlands Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 58: The Netherlands Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 59: Rest of Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 60: Rest of Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 61: Rest of Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 62: Rest of Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 63: Rest of Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 64: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 65: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 66: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 67: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 68: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 69: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 70: China Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 71: China Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 72: China Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 73: China Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 74: China Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 75: India Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 76: India Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 77: India Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 78: India Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 79: India Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 80: Japan Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 81: Japan Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 82: Japan Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 83: Japan Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 84: Japan Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 85: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 86: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 87: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 88: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 89: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 90: Australia & New Zealand Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 91: Australia & New Zealand Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 92: Australia & New Zealand Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 93: Australia & New Zealand Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 94: Australia & New Zealand Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 95: ASEAN Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 96: ASEAN Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 97: ASEAN Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 98: ASEAN Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 99: ASEAN Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 100: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 101: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 102: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 103: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 104: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 105: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 106: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 107: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 108: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 109: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 110: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 111: Brazil Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 112: Brazil Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 113: Brazil Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 114: Brazil Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 115: Brazil Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 116: Argentina Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 117: Argentina Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 118: Argentina Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 119: Argentina Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 120: Argentina Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 121: Mexico Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 122: Mexico Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 123: Mexico Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 124: Mexico Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 125: Mexico Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 126: Rest of Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 127: Rest of Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 128: Rest of Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 129: Rest of Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 130: Rest of Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 131: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021-2036
Table 132: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 133: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 134: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 135: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 136: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 137: GCC Countries Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 138: GCC Countries Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 139: GCC Countries Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 140: GCC Countries Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 141: GCC Countries Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 142: South Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 143: South Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 144: South Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 145: South Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 146: South Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036
Table 147: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Therapy Type, 2021 to 2036
Table 148: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2021 to 2036
Table 149: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Prescription Type, 2021 to 2036
Table 150: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2021 to 2036
Table 151: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2021 to 2036

List of Figures

Figure 01: Global Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 02: Global Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 03: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs), 2021 to 2036
Figure 04: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Chloride Channel Activators, 2021 to 2036
Figure 05: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Traditional Laxatives, 2021 to 2036
Figure 06: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 07: Global Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 08: Global Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 09: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Branded Drugs, 2021 to 2036
Figure 10: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Generic Drugs, 2021 to 2036
Figure 11: Global Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 12: Global Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 13: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Over-The-Counter, 2021 to 2036
Figure 14: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Prescription, 2021 to 2036
Figure 15: Global Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 16: Global Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 17: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Oral, 2021 to 2036
Figure 18: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Subcutaneous, 2021 to 2036
Figure 19: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 20: Global Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 21: Global Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 22: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2021 to 2036
Figure 23: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2021 to 2036
Figure 24: Global Opioid Induced Constipation Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2021 to 2036
Figure 25: Global Opioid Induced Constipation Treatment Market Value Share Analysis, By Region, 2025 and 2036
Figure 26: Global Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Region, 2026 to 2036
Figure 27: North America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 28: North America Opioid Induced Constipation Treatment Market Value Share Analysis, by Country, 2025 and 2036
Figure 29: North America Opioid Induced Constipation Treatment Market Attractiveness Analysis, by Country, 2026 to 2036
Figure 30: North America Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 31: North America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 32: North America Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 33: North America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 34: North America Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 35: North America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 36: North America Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 37: North America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 38: North America Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 39: North America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 40: U.S. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 41: U.S. Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 42: U.S. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 43: U.S. Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 44: U.S. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 45: U.S. Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 46: U.S. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 47: U.S. Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 48: U.S. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 49: U.S. Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 50: U.S. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 51: Canada Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 52: Canada Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 53: Canada Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 54: Canada Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 55: Canada Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 56: Canada Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 57: Canada Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 58: Canada Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 59: Canada Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 60: Canada Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 61: Canada Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 62: Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 63: Europe Opioid Induced Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 64: Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 65: Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 66: Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 67: Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 68: Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 69: Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 70: Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 71: Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 72: Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 73: Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 74: Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 75: Germany Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 76: Germany Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 77: Germany Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 78: Germany Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 79: Germany Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 80: Germany Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 81: Germany Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 82: Germany Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 83: Germany Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 84: Germany Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 85: Germany Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 86: U.K. Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 87: U.K. Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 88: U.K. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 89: U.K. Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 90: U.K. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 91: U.K. Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 92: U.K. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 93: U.K. Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 94: U.K. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 95: U.K. Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 96: U.K. Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 97: France Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 98: France Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 99: France Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 100: France Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 101: France Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 102: France Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 103: France Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 104: France Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 105: France Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 106: France Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 107: France Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 108: Italy Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 109: Italy Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 110: Italy Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 111: Italy Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 112: Italy Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 113: Italy Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 114: Italy Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 115: Italy Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 116: Italy Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 117: Italy Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 118: Italy Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 119: Spain Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 120: Spain Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 121: Spain Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 122: Spain Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 123: Spain Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 124: Spain Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 125: Spain Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 126: Spain Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 127: Spain Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 128: Spain Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 129: Spain Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 130: The Netherlands Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 131: The Netherlands Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 132: The Netherlands Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 133: The Netherlands Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 134: The Netherlands Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 135: The Netherlands Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 136: The Netherlands Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 137: The Netherlands Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 138: The Netherlands Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 139: The Netherlands Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 140: The Netherlands Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 141: Rest of Europe Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 142: Rest of Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 143: Rest of Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 144: Rest of Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 145: Rest of Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 146: Rest of Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 147: Rest of Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 148: Rest of Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 149: Rest of Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 150: Rest of Europe Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 151: Rest of Europe Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 152: Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 153: Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 154: Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 155: Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 156: Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 157: Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 158: Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 159: Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 160: Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 161: Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 162: Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 163: Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 164: Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 165: China Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 166: China Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 167: China Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 168: China Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 169: China Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 170: China Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 171: China Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 172: China Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 173: China Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 174: China Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 175: China Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 176: India Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 177: India Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 178: India Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 179: India Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 180: India Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 181: India Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 182: India Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 183: India Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 184: India Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 185: India Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 186: India Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 187: Japan Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 188: Japan Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 189: Japan Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 190: Japan Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 191: Japan Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 192: Japan Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 193: Japan Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 194: Japan Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 195: Japan Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 196: Japan Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 197: Japan Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 198: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 199: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 200: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 201: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 202: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 203: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 204: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 205: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 206: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 207: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 208: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 209: Australia & New Zealand Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 210: Australia & New Zealand Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 211: Australia & New Zealand Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 212: Australia & New Zealand Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 213: Australia & New Zealand Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 214: Australia & New Zealand Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 215: Australia & New Zealand Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 216: Australia & New Zealand Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 217: Australia & New Zealand Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 218: Australia & New Zealand Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 219: Australia & New Zealand Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 220: ASEAN Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 221: ASEAN Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 222: ASEAN Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 223: ASEAN Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 224: ASEAN Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 225: ASEAN Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 226: ASEAN Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 227: ASEAN Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 228: ASEAN Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 229: ASEAN Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 230: ASEAN Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 231: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 232: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 233: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 234: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 235: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 236: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 237: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 238: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 239: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 240: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 241: Rest of Asia Pacific Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 242: Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 243: Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 244: Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 245: Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 246: Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 247: Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 248: Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 249: Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 250: Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 251: Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 252: Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 253: Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 254: Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 255: Brazil Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 256: Brazil Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 257: Brazil Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 258: Brazil Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 259: Brazil Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 260: Brazil Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 261: Brazil Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 262: Brazil Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 263: Brazil Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 264: Brazil Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 265: Brazil Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 266: Argentina Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 267: Argentina Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 268: Argentina Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 269: Argentina Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 270: Argentina Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 271: Argentina Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 272: Argentina Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 273: Argentina Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 274: Argentina Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 275: Argentina Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 276: Argentina Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 277: Mexico Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 278: Mexico Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 279: Mexico Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 280: Mexico Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 281: Mexico Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 282: Mexico Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 283: Mexico Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 284: Mexico Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 285: Mexico Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 286: Mexico Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 287: Mexico Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 288: Rest of Latin America Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 289: Rest of Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 290: Rest of Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 291: Rest of Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 292: Rest of Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 293: Rest of Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 294: Rest of Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 295: Rest of Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 296: Rest of Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 297: Rest of Latin America Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 298: Rest of Latin America Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 299: Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 300: Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 301: Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 302: Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 303: Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 304: Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 305: Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 306: Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 307: Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 308: Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 309: Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 310: Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 311: Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 312: GCC Countries Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 313: GCC Countries Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 314: GCC Countries Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 315: GCC Countries Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 316: GCC Countries Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 317: GCC Countries Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 318: GCC Countries Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 319: GCC Countries Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 320: GCC Countries Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 321: GCC Countries Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 322: GCC Countries Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 323: South Korea Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 324: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 325: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 326: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 327: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 328: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 329: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 330: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 331: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 332: South Korea Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 333: South Korea Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036
Figure 334: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 335: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Therapy Type, 2025 and 2036
Figure 336: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Therapy Type, 2026 to 2036
Figure 337: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Drug Type, 2025 and 2036
Figure 338: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Drug Type, 2026 to 2036
Figure 339: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Prescription Type, 2025 and 2036
Figure 340: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Prescription Type, 2026 to 2036
Figure 341: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Route of Administration, 2025 and 2036
Figure 342: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Route of Administration, 2026 to 2036
Figure 343: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Value Share Analysis, By Distribution Channel, 2025 and 2036
Figure 344: Rest of Middle East & Africa Opioid Induced Constipation Treatment Market Attractiveness Analysis, By Distribution Channel, 2026 to 2036